SCHEMBL4672467

SCHEMBL4672467

CCCOC(=O)C(C)(C)O

nearest known ligand 0.40

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
HCAR2 Q8TDS4 1/20 0.40
ALDH1A1 P00352 6/20 0.39
LMNA P02545 2/20 0.38
TSHR P16473 2/20 0.36
CHRM1 P11229 2/20 0.36
ESR1 P03372 1/20 0.36
SLC6A2 P23975 1/20 0.36
KDR P35968 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
HSD17B10 Q99714 1/20 0.34
RAB9A P51151 1/20 0.34
ATM Q13315 1/20 0.33
GRM1 Q13255 1/20 0.33
CHRM2 P08172 1/20 0.33
CHRM4 P08173 1/20 0.33
CHRM5 P08912 1/20 0.33
CHRM3 P20309 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL442926 0.86 ALDH1A1 (0.54) HCAR2ALDH1A1LMNATSHRESR1
SCHEMBL27984406 0.85 HCAR2 (0.40) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL4672633 0.84 NAAA (0.52) HCAR2ALDH1A1LMNATSHRATM
SCHEMBL23581545 0.82 NAAA (0.55) HCAR2ALDH1A1LMNATSHR
SCHEMBL29754027 0.82 NAAA (0.55) HCAR2ALDH1A1LMNATSHR
SCHEMBL9487820 0.82 NAAA (0.55) HCAR2ALDH1A1LMNATSHR
SCHEMBL1548335 0.82 NAAA (0.55) HCAR2ALDH1A1LMNATSHR
SCHEMBL6062638 0.82 HCAR2 (0.41) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL26327281 0.82 HCAR2 (0.41) HCAR2ALDH1A1LMNATSHRCHRM1
SCHEMBL204763 0.82 POLB (0.44) HCAR2ALDH1A1LMNATSHRCHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110874025-B Diluent composition, substrate processing method and semiconductor element manufacturing method 易案爱富科技有限公司 2024-05-24 CN claimed
US-11220659-B2 Thinner composition ENF TECHNOLOGY CO., LTD. (KR) 2022-01-11 US claimed
US-11046634-B2 High-purity carboxylic acid ester and method for producing same MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2021-06-29 US claimed
CN-110874025-A Thinner composition, substrate processing method and semiconductor device manufacturing method 易案爱富科技有限公司 2020-03-10 CN claimed
US-20200071640-A1 THINNER COMPOSITION ENF TECHNOLOGY CO., LTD. (KR) 2020-03-05 US claimed
US-20180273465-A1 HIGH-PURITY CARBOXYLIC ACID ESTER AND METHOD FOR PRODUCING SAME MITSUBISHI GAS CHEMICAL COMPANY, INC. (JP) 2018-09-27 US claimed
CN-108137476-A High-purity carboxylate and its manufacturing method 三菱瓦斯化学株式会社 2018-06-08 CN claimed
US-9568830-B2 Thinner composition for improving coating and removing performance of resist DONGWOO FINE-CHEM CO., LTD. (KR) 2017-02-14 US claimed
US-20150355545-A1 THINNER COMPOSITION FOR IMPROVING COATING AND REMOVING PERFORMANCE OF RESIST DONGWOO FINE-CHEM CO., LTD. (KR) 2015-12-10 US claimed
WO-2006119283-A2 ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE YU RUEY J (US) 2006-11-09 WO claimed
US-20060251597-A1 ANTI-ODOR COMPOSITIONS AND THERAPEUTIC USE YU RUEY J 2006-11-09 US claimed
CN-116560190-B Resist material and pattern forming method SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-05-26 CN disclosed
US-12625429-B2 Resist composition and pattern forming process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-05-12 US disclosed
US-12596303-B2 Resist composition and pattern forming process SHIN-ETSU CHEMICAL CO., LTD. (JP) 2026-04-07 US disclosed
US-20250230356-A1 THINNER COMPOSITION DONGWOO FINE-CHEM CO., LTD. (KR) 2025-07-17 US disclosed
EP-1101761-A2 Process for producing 3-phenyluracil compounds SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-05-23 EP disclosed
EP-1095935-A1 6-Hydroxy-5,6-dihydrouracils as herbicides SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2001-05-02 EP disclosed
US-6146816-A DEVELOPER LIQUID FOR NEGATIVE WORKING RADIATION SENSITIVE COMPOSITIONS WHICH INCLUDES AN ALKYL ESTER OF A HYDROXY CARBOXYLIC ACID. AGFA-GEVAERT, N.V. (BE) 2000-11-14 US disclosed
EP-1006412-A1 Development of radiation sensitive compositions AGFA-GEVAERT N.V. (BE) 2000-06-07 EP disclosed
US-3974207-A Method for producing methacrylic esters Instyut Ciezkiej Syntesy Organiczej "Blachownia" (PO) 1976-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12625429-B2 Resist composition and pattern forming process NAF1, CLIC1, H1-4 HCAR2 898/4885ALDH1A1 1604/4885LMNA 2432/4885
US-12596303-B2 Resist composition and pattern forming process CBR1, CCR1, NAF1 HCAR2 440/4885ALDH1A1 2963/4885LMNA 2549/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.